2010 Medical Innovation Summit to Showcase Innovations in Treating Obesity&Diabetes
Cleveland Clinic has finalized the agenda for the 8th Annual Medical Innovation Summit, which will be held Nov. 1-3 on the Clinic’s campus. The Summit draws 1,000 attendees each year, and includes panel discussions with some of the industry’s top CEOs and thought leaders.
This year’s summit will highlight breakthrough technologies for diagnosing and treating obesity and diabetes. Top executives, investors, entrepreneurs, clinicians and technologists will gather to share ideas on how to combat this devastating epidemic.
“Since 1980, obesity rates have doubled in the United States, not only increasing the likelihood of diabetes, but also a number of other significant health risks,” said Chris Coburn, Executive Director of Cleveland Clinic Innovations. “This year’s summit brings together the decision makers who are developing new technologies to diagnose, treat and manage these diseases. We have assembled the top executives, highest impact technologies, most active investors and leading clinicians to highlight the issues and opportunities for this important area of medical innovation.”
The 2010 Medical Innovation Summit will feature more than 40 international leaders including: CEOs Bill Weldon (Johnson & Johnson), Chris Viehbacher (Sanofi-aventis), John Lechleiter (Eli Lilly), Kevin Sharer (Amgen), John Hammergren (McKesson), William Hawkins (Medtronic), Stephen MacMillan (Stryker), Rich Meelia (Covidien), Angela Braly (Wellpoint), and Tim Ring (Bard); best-selling author and host of “The Dr. Oz Show,” Dr. Mehmet Oz; media moderators Maria Bartiromo (CNBC) and Ron Winslow (Wall Street Journal); CEOs of more than a dozen emerging technology companies; and the Commissioner of the Patent and Trademark Office.
For a complete list of speakers, visit:
In addition, for the fifth consecutive year, Cleveland Clinic will unveil its list of the “Top 10” Medical Innovations that will have a significant impact in 2010. The panel discussion of the innovations will be chaired by best-selling author and Cleveland Clinic’s Chief Wellness Officer Michael Roizen, M.D.
For a list of previous “Top 10” winners, visit
About Cleveland Clinic Innovations
Innovations, the corporate venturing arm of Cleveland Clinic, promotes innovation and is responsible for the commercialization of all Cleveland Clinic technologies. Innovations advances product-oriented innovation and transforms promising therapies, devices, diagnostics and software into beneficial medical products, via spin-off companies, licensees and equity partnerships. There have been 33 companies spun off from the Clinic in the last decade, more than 200 licenses, more than $340 million in equity investment in those spin-offs and a record number of inventions in virtually every area of activity at Cleveland Clinic. In 2010, Cleveland Clinic Innovations was named one of the Most Influential Healthcare Corporate Venturing Divisions by the Global Corporate Venturing.